PYRAZOLO[1,5-A]PYRAZINE DERIVATIVES AS BTK INHIBITORS
Provided are compounds of Formula (I'): or pharmaceutically acceptable salts thereof, wherein the variables in the formula are as defined herein; and methods for their use and production.
Saved in:
| Main Authors | , , , , , , , , , , , , , , , , |
|---|---|
| Format | Patent |
| Language | English French German |
| Published |
20.09.2023
|
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | Provided are compounds of Formula (I'): or pharmaceutically acceptable salts thereof, wherein the variables in the formula are as defined herein; and methods for their use and production. |
|---|---|
| AbstractList | Provided are compounds of Formula (I'): or pharmaceutically acceptable salts thereof, wherein the variables in the formula are as defined herein; and methods for their use and production. |
| Author | PURGETT, Thomas MARX, Isaac CHEN, Teyu PRINCE, Robin NEVALAINEN, Marta PATTAROPONG, Vatee HIMMELBAUER, Martin HOPKINS, Brian, T JONES, John, Howard VANDEVEER, George SCIABOLA, Simone YOUSAF, Zain SCHULZ, Jurgen LIN, Edward, Yin-shiang MA, Bin CAPACCI, Andrew, George GONZALEZ LOPEZ DE TURISO, Felix |
| Author_xml | – fullname: PRINCE, Robin – fullname: MARX, Isaac – fullname: LIN, Edward, Yin-shiang – fullname: PATTAROPONG, Vatee – fullname: CAPACCI, Andrew, George – fullname: JONES, John, Howard – fullname: SCHULZ, Jurgen – fullname: VANDEVEER, George – fullname: YOUSAF, Zain – fullname: HIMMELBAUER, Martin – fullname: HOPKINS, Brian, T – fullname: CHEN, Teyu – fullname: MA, Bin – fullname: NEVALAINEN, Marta – fullname: GONZALEZ LOPEZ DE TURISO, Felix – fullname: PURGETT, Thomas – fullname: SCIABOLA, Simone |
| BookMark | eNrjYmDJy89L5WQwDYgMcozy9_GPNtQx1XWMBXM9_VwVXFyDPMMcQzzDXIMVHIMVnEK8FTz9PDydPEP8g4J5GFjTEnOKU3mhNDeDgptriLOHbmpBfnxqcUFicmpeakm8a4CJkYmJkZGxo6ExEUoAx4IpTA |
| ContentType | Patent |
| DBID | EVB |
| DatabaseName | esp@cenet |
| DatabaseTitleList | |
| Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine Chemistry Sciences |
| DocumentTitleAlternate | PYRAZOLO[1,5-A PYRAZINDERIVATE ALS BTK INHIBITOREN DÉRIVÉS DE PYRAZOLO[1,5-A]PYRAZINE UTILISÉS EN TANT QU'INHIBITEURS DE BTK |
| ExternalDocumentID | EP4244223A1 |
| GroupedDBID | EVB |
| ID | FETCH-epo_espacenet_EP4244223A13 |
| IEDL.DBID | EVB |
| IngestDate | Fri Jul 19 13:07:02 EDT 2024 |
| IsOpenAccess | true |
| IsPeerReviewed | false |
| IsScholarly | false |
| Language | English French German |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-epo_espacenet_EP4244223A13 |
| Notes | Application Number: EP20210823425 |
| OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20230920&DB=EPODOC&CC=EP&NR=4244223A1 |
| ParticipantIDs | epo_espacenet_EP4244223A1 |
| PublicationCentury | 2000 |
| PublicationDate | 20230920 |
| PublicationDateYYYYMMDD | 2023-09-20 |
| PublicationDate_xml | – month: 09 year: 2023 text: 20230920 day: 20 |
| PublicationDecade | 2020 |
| PublicationYear | 2023 |
| RelatedCompanies | Biogen MA Inc |
| RelatedCompanies_xml | – name: Biogen MA Inc |
| Score | 3.4883385 |
| Snippet | Provided are compounds of Formula (I'): or pharmaceutically acceptable salts thereof, wherein the variables in the formula are as defined herein; and methods... |
| SourceID | epo |
| SourceType | Open Access Repository |
| SubjectTerms | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| Title | PYRAZOLO[1,5-A]PYRAZINE DERIVATIVES AS BTK INHIBITORS |
| URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20230920&DB=EPODOC&locale=&CC=EP&NR=4244223A1 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LT4NAEJ401ag3rRrrK3swnCQCLRQOxPAMqAUCSKrGNDyTXmhjMf59hw2tXnRP-0j2lXw78-3OzALcKKP2S5wSgTSpZCQoqcjKJXKeTJRSrsA0pnG6p57kPI8fZuKsB4uNLwyNE_pFgyMionLEe0PP69XPJZZJbSvXd9kCq5b3dqyaTMeOUZ9WBI4xddUKfNM3GMPAHOOFauvPhZJQQ6K0g1r0pAWDleitU8rqt0SxD2E3wM7q5gh6ZT2AfWPz8doA9qbdezdmO-itj0EMXkLt1X_y3_hbkdXeadH1LGIiFUu02E2siGgR0eNH4nqOq7uxH0YnQGwrNhwWx59v1zq3gu1MR6fQr5d1eQYkL6RSyFA3kioFNQhJ5lOpyHmUtmkuVzk_hOGf3Zz_03YBB-2mtfYPAncJ_ebjs7xCIdtk13R7vgHxm3wc |
| link.rule.ids | 230,309,783,888,25576,76882 |
| linkProvider | European Patent Office |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LT4NAEJ401VhvWjXWJwfDSSK0BemBGJ4ByystkmpjCFBIeqGNxfj3nd3Q6kX3NLubzD6S2Zlvd2cG4G40IClxChSkx1JGgJKKnFwg5slEKeUXWIY0TrfnS_bL8Hkmzlqw3PrC0DihXzQ4IkpUjvJe0_N6_XOJZdC_lZuHbIlNqycrUgy2QcdoT4_6PGtoihkGRqCzuo4U608U4s-FmlBFoLSHFrZMkh2YsUacUta_NYp1BPshMqvqY2gVVRc6-jbxWhcOvOa9G8lG9DYnIIavE_UtcIO5cC9y6jutOr7JGAjFYjVyYnPKqFNGi8aM49uO5kTBZHoKjGVGus3h-MlurYkZ7mY6OIN2taqKc2DyhVT0M7SNpHKEFoQkC6m0yAXUtmkul7nQg96fbC7-6buFjh15buI6_vgSDskGkr8Qff4K2vXHZ3GNCrfObuhWfQPrPX8M |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=PYRAZOLO%5B1%2C5-A%5DPYRAZINE+DERIVATIVES+AS+BTK+INHIBITORS&rft.inventor=PRINCE%2C+Robin&rft.inventor=MARX%2C+Isaac&rft.inventor=LIN%2C+Edward%2C+Yin-shiang&rft.inventor=PATTAROPONG%2C+Vatee&rft.inventor=CAPACCI%2C+Andrew%2C+George&rft.inventor=JONES%2C+John%2C+Howard&rft.inventor=SCHULZ%2C+Jurgen&rft.inventor=VANDEVEER%2C+George&rft.inventor=YOUSAF%2C+Zain&rft.inventor=HIMMELBAUER%2C+Martin&rft.inventor=HOPKINS%2C+Brian%2C+T&rft.inventor=CHEN%2C+Teyu&rft.inventor=MA%2C+Bin&rft.inventor=NEVALAINEN%2C+Marta&rft.inventor=GONZALEZ+LOPEZ+DE+TURISO%2C+Felix&rft.inventor=PURGETT%2C+Thomas&rft.inventor=SCIABOLA%2C+Simone&rft.date=2023-09-20&rft.externalDBID=A1&rft.externalDocID=EP4244223A1 |